Steven N. Hart

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• Design considerations for workflow management systems use in production genomics research and the clinic.
  2021 L1 57/100

1 assessed by us (0 reproduced) · 340 not yet assessed — every PubMed paper on record, linked below.

• Enhancing missense variant classification in predicted intrinsically disordered regions ↗

  PLoS ONE · 2026 · PMID 42507643
  not yet assessed
• Artificial intelligence in pathology: a framework for preserving brain capital in the diagnostic apex ↗

  Croatian Medical Journal · 2026
  not yet assessed
• AI and Pathology Training ↗

  2026
  not yet assessed
• The CARE framework for AI dataset documentation in clinical laboratories: a comprehensive checklist and data lineage methodology ↗

  American Journal of Clinical Pathology · 2026 · PMID 42114029
  not yet assessed
• The survival double descent: generalization dynamics of deep neural networks in time-to-event analysis ↗

  BMC Medical Research Methodology · 2026 · PMID 42237249
  not yet assessed
• Functional evaluation and clinical classification of BRCA2 variants ↗

  Nature · 2025 · PMID 39779857
  not yet assessed
• Association of gene variant type and location with breast cancer risk in the general population ↗

  Annals of Oncology · 2025 · PMID 40288678
  not yet assessed
• Establishing a comprehensive artificial intelligence lifecycle framework for laboratory medicine and pathology: A series introduction ↗

  American Journal of Clinical Pathology · 2025 · PMID 40650598
  not yet assessed
• Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification ↗

  Nature Communications · 2025 · PMID 40413188
  not yet assessed
• Streamlining medical software development with CARE lifecycle and CARE agent: an AI-driven technology readiness level assessment tool ↗

  BMC Medical Informatics and Decision Making · 2025 · PMID 40629334
  not yet assessed
• Agent-Based Large Language Model System for Extracting Structured Data from Breast Cancer Synoptic Reports: A Dual-Validation Study ↗

  medRxiv · 2025
  not yet assessed
• Mammographic density, pathogenic breast cancer susceptibility gene variants and breast cancer risk ↗

  medRxiv · 2025
  not yet assessed
• LB1048 Assessment of cutaneous tissue using light-sheet microscopy: Evaluating feasibility of 3D-microscopy for mohs micrographic surgery ↗

  Journal of Investigative Dermatology · 2025
  not yet assessed
• Genomic and Immune Landscape of Pancreatic Ductal Adenocarcinoma Associated with Germline Pathogenic Variants in ATM ↗

  Clinical Cancer Research · 2025 · PMID 40828413
  not yet assessed
• Supplementary Figures S1-S12 from Genomic and Immune Landscape of Pancreatic Ductal Adenocarcinoma Associated with Germline Pathogenic Variants in ATM ↗

  2025
  not yet assessed
• Data from Genomic and Immune Landscape of Pancreatic Ductal Adenocarcinoma Associated with Germline Pathogenic Variants in ATM ↗

  2025
  not yet assessed
• Supplementary Table S3 from Genomic and Immune Landscape of Pancreatic Ductal Adenocarcinoma Associated with Germline Pathogenic Variants in ATM ↗

  2025
  not yet assessed
• Supplementary Table S1 from Genomic and Immune Landscape of Pancreatic Ductal Adenocarcinoma Associated with Germline Pathogenic Variants in ATM ↗

  2025
  not yet assessed
• Supplementary Table S4 from Genomic and Immune Landscape of Pancreatic Ductal Adenocarcinoma Associated with Germline Pathogenic Variants in ATM ↗

  2025
  not yet assessed
• Supplementary Table S5 from Genomic and Immune Landscape of Pancreatic Ductal Adenocarcinoma Associated with Germline Pathogenic Variants in ATM ↗

  2025
  not yet assessed
• Supplementary Table S2 from Genomic and Immune Landscape of Pancreatic Ductal Adenocarcinoma Associated with Germline Pathogenic Variants in ATM ↗

  2025
  not yet assessed
• Supplementary Materials, Figure S1-S4, Table S1-S9 from Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C ↗

  2025
  not yet assessed
• Mammographic density, pathogenic breast cancer susceptibility gene variants, and breast cancer risk: a pooled case–control analysis ↗

  Apollo (University of Cambridge) · 2025
  not yet assessed
• Harnessing the Power of Generative Artificial Intelligence in Pathology Education: Opportunities, Challenges, and Future Directions ↗

  Archives of Pathology & Laboratory Medicine · 2024 · PMID 39343982
  not yet assessed
• Image‐based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno‐oncology Biomarker Working Group on Breast Cancer ↗

  The Journal of Pathology · 2024 · PMID 38230434
  not yet assessed
• Deep Learning in Automating Breast Cancer Diagnosis from Microscopy Images ↗

  2024
  not yet assessed
• Enhancing human phenotype ontology term extraction through synthetic case reports and embedding-based retrieval: A novel approach for improved biomedical data annotation ↗

  Journal of Pathology Informatics · 2024 · PMID 39720417
  not yet assessed
• Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer ↗

  npj Breast Cancer · 2024 · PMID 39003306
  not yet assessed
• Bridging the Clinical-Computational Transparency Gap in Digital Pathology ↗

  Archives of Pathology & Laboratory Medicine · 2024 · PMID 38871349
  not yet assessed
• Democratizing Artificial Intelligence in Anatomic Pathology ↗

  Archives of Pathology & Laboratory Medicine · 2024 · PMID 38649149
  not yet assessed
• Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification ↗

  medRxiv · 2024 · PMID 39281752
  not yet assessed
• O17 Highly efficient base editing of homozygous and heterozygous COL7A1 variants in fibroblasts from patients with recessive dystrophic epidermolysis bullosa using adenine base editor 8e mRNA system delivered via novel lipid nanoparticle formulations ↗

  British Journal of Dermatology · 2024
  not yet assessed
• Generative AI impact on protein stability prediction in breast cancer genes ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2024
  not yet assessed
• Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study ↗

  Kölner Universitäts PublikationsServer (Universität zu Köln) · 2024
  not yet assessed
• Breast cancer risk factors and survival by tumor subtype: Pooled analyses from the breast cancer association consortium ↗

  Carolina Digital Repository (University of North Carolina at Chapel Hill) · 2024
  not yet assessed
• Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment ↗

  Carolina Digital Repository (University of North Carolina at Chapel Hill) · 2024
  not yet assessed
• Data from Functional and clinical characterization of variants of uncertain significance identifies a hotspot for inactivating missense variants in RAD51C ↗

  2024
  not yet assessed
• Supplementary Materials, Figure S1-S4, Table S1-S9 from Functional and clinical characterization of variants of uncertain significance identifies a hotspot for inactivating missense variants in RAD51C ↗

  2024
  not yet assessed
• Supplementary Materials, Figure S1-S4, Table S1-S9 from Functional and clinical characterization of variants of uncertain significance identifies a hotspot for inactivating missense variants in RAD51C ↗

  2024
  not yet assessed
• Using AI-predicted protein structures as a reference to predict loss-of-function activity in tumor suppressor breast cancer genes ↗

  Computational and Structural Biotechnology Journal · 2024 · PMID 39430403
  not yet assessed
• Association of Gene Variant Type and Location with Breast Cancer Risk in the General Population ↗

  medRxiv · 2024 · PMID 39417132
  not yet assessed
• Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM , BRCA1 , BRCA2 , CHEK2 , and PALB2 ↗

  Journal of Clinical Oncology · 2023 · PMID 36623243
  not yet assessed
• Pitfalls in machine learning‐based assessment of tumor‐infiltrating lymphocytes in breast cancer: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer ↗

  The Journal of Pathology · 2023 · PMID 37608772
  not yet assessed
• Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer ↗

  The Journal of Pathology · 2023 · PMID 37608771
  not yet assessed
• Organizational preparedness for the use of large language models in pathology informatics ↗

  Journal of Pathology Informatics · 2023 · PMID 37860713
  not yet assessed
• Cybersecurity and Information Assurance for the Clinical Laboratory ↗

  The Journal of Applied Laboratory Medicine · 2023 · PMID 36610432
  not yet assessed
• Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C ↗

  Cancer Research · 2023 · PMID 37253112
  not yet assessed
• Using an anomaly detection approach for the segmentation of colorectal cancer tumors in whole slide images ↗

  Journal of Pathology Informatics · 2023 · PMID 37811333
  not yet assessed
• Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  Cancer Research Communications · 2023 · PMID 38014910
  not yet assessed
• Initial interactions with the FDA on developing a validation dataset as a medical device development tool ↗

  The Journal of Pathology · 2023 · PMID 37794720
  not yet assessed
• Succinate dehydrogenase variants in paraganglioma: why are B subunit variants ‘bad’? ↗

  Endocrine Oncology · 2023 · PMID 37434649
  not yet assessed
• Saturation genome editing-based functional evaluation and clinical classification of BRCA2 single nucleotide variants ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2023 · PMID 38168194
  not yet assessed
• Abstract GS4-04: Population-based Estimates of contralateral Breast Cancer Risk among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2 ↗

  Cancer Research · 2023
  not yet assessed
• Deep Learning in Automating Breast Cancer Diagnosis from Microscopy Images ↗

  medRxiv · 2023
  not yet assessed
• Using an Anomaly Detection Approach for the Segmentation of Colorectal Cancer Tumors in Whole Slide Images ↗

  medRxiv · 2023
  not yet assessed
• Data from Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease ↗

  2023
  not yet assessed
• Data from Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease ↗

  2023
  not yet assessed
• Data from Genetic Risk of Second Primary Cancer in Breast Cancer Survivors: The Multiethnic Cohort Study ↗

  2023
  not yet assessed
• Supplemental Table 2 from Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease ↗

  2023
  not yet assessed
• Supplemental Figure Legeneds from Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease ↗

  2023
  not yet assessed
• Supplemental Table 3 from Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease ↗

  2023
  not yet assessed
• Supplemental Figures and Table 1 from Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease ↗

  2023
  not yet assessed
• Supplemental Table 2 from Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease ↗

  2023
  not yet assessed
• Supplemental Figure Legeneds from Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease ↗

  2023
  not yet assessed
• Hu Supplementary data Resubmission from Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients ↗

  2023
  not yet assessed
• Supplementary Data from Effect of Germline Mutations in Homologous Recombination Repair Genes on Overall Survival of Patients with Pancreatic Adenocarcinoma ↗

  2023
  not yet assessed
• Supplementary Methods, Tables 1 - 6, Figures 1 - 5 from APOBEC3B Upregulation and Genomic Mutation Patterns in Serous Ovarian Carcinoma ↗

  2023
  not yet assessed
• Supplementary Figure from Genetic Risk of Second Primary Cancer in Breast Cancer Survivors: The Multiethnic Cohort Study ↗

  2023
  not yet assessed
• Supplementary Data from Effect of Germline Mutations in Homologous Recombination Repair Genes on Overall Survival of Patients with Pancreatic Adenocarcinoma ↗

  2023
  not yet assessed
• Data from Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients ↗

  2023
  not yet assessed
• Data from Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients ↗

  2023
  not yet assessed
• Data from Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay ↗

  2023
  not yet assessed
• Data from Effect of Germline Mutations in Homologous Recombination Repair Genes on Overall Survival of Patients with Pancreatic Adenocarcinoma ↗

  2023
  not yet assessed
• Data from Effect of Germline Mutations in Homologous Recombination Repair Genes on Overall Survival of Patients with Pancreatic Adenocarcinoma ↗

  2023
  not yet assessed
• Supplementary Table from Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay ↗

  2023
  not yet assessed
• Supplementary Table from Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay ↗

  2023
  not yet assessed
• Data from Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay ↗

  2023
  not yet assessed
• Supplementary Table from Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay ↗

  2023
  not yet assessed
• Supplementary Table from Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay ↗

  2023
  not yet assessed
• Supplemental Table 3 from Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease ↗

  2023
  not yet assessed
• Supplemental Figures and Table 1 from Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease ↗

  2023
  not yet assessed
• Supplementary Figure from Genetic Risk of Second Primary Cancer in Breast Cancer Survivors: The Multiethnic Cohort Study ↗

  2023
  not yet assessed
• Hu Supplementary data Resubmission from Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients ↗

  2023
  not yet assessed
• Supplementary Methods, Tables 1 - 6, Figures 1 - 5 from APOBEC3B Upregulation and Genomic Mutation Patterns in Serous Ovarian Carcinoma ↗

  2023
  not yet assessed
• Supplementary Figures 1 - 6, Tables 1 - 2 from A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer ↗

  2023
  not yet assessed
• Supplementary Figures 1 - 6, Tables 1 - 2 from A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer ↗

  2023
  not yet assessed
• Data from Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C ↗

  2023
  not yet assessed
• Supplementary Materials, Figure S1-S4, Table S1-S9 from Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C ↗

  2023
  not yet assessed
• Supplementary Materials, Figure S1-S4, Table S1-S9 from Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C ↗

  2023
  not yet assessed
• Data from Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C ↗

  2023
  not yet assessed
• Data from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 3 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Figure 1 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 11 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 19 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 21 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 18 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 13 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 14 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 2 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 5 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 7 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 3 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 7 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 5 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 1 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 15 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 6 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 13 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 16 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 4 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 10 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 11 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 20 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 18 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 2 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 8 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 17 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 17 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 20 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• TABLE 1 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 10 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 6 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• TABLE 1 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 8 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 4 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 1 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 14 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 12 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Data from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 9 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 16 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 12 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 9 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Figure 1 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 21 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 15 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Supplementary Table 19 from Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry ↗

  2023
  not yet assessed
• Saturation genome editing-based functional evaluation and clinical classification of BRCA2 single nucleotide variants ↗

  Research Square · 2023
  not yet assessed
• Data from Genetic Risk of Second Primary Cancer in Breast Cancer Survivors: The Multiethnic Cohort Study ↗

  2023
  not yet assessed
• Data from APOBEC3B Upregulation and Genomic Mutation Patterns in Serous Ovarian Carcinoma ↗

  2023
  not yet assessed
• Data from A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer ↗

  2023
  not yet assessed
• Data from A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer ↗

  2023
  not yet assessed
• Data from APOBEC3B Upregulation and Genomic Mutation Patterns in Serous Ovarian Carcinoma ↗

  2023
  not yet assessed
• Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study ↗

  British Journal of Sports Medicine · 2022 · PMID 36328784
  not yet assessed
• Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities ↗

  Nature Communications · 2022 · PMID 35082299
  not yet assessed
• Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants ↗

  JAMA Oncology · 2022 · PMID 35175286
  not yet assessed
• Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay ↗

  Clinical Cancer Research · 2022 · PMID 35736817
  not yet assessed
• Genetic Risk of Second Primary Cancer in Breast Cancer Survivors: The Multiethnic Cohort Study ↗

  Cancer Research · 2022 · PMID 35834270
  not yet assessed
• USING PROGRESSIVE CONTEXT ENCODERS FOR ANOMALY DETECTION IN DIGITAL PATHOLOGY IMAGES ↗

  Journal of Pathology Informatics · 2022
  not yet assessed
• An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significance ↗

  npj Genomic Medicine · 2022 · PMID 35665744
  not yet assessed
• Abstract PO-197: Combined effect of a prostate cancer polygenic risk score and germline pathogenic variants in DNA damage repair genes on prostate cancer risk in men of African ancestry ↗

  Cancer Epidemiology Biomarkers & Prevention · 2022
  not yet assessed
• Abstract P2-09-01: Population-based risk estimates of clinical subtypes of breast cancer among carriers of germline pathogenic variants in cancer predisposition genes ↗

  Cancer Research · 2022
  not yet assessed
• DICOM_WSI: A PYTHON IMPLEMENTATION FOR CONVERTING WHOLE-SLIDE IMAGES TO DIGITAL IMAGING AND COMMUNICATIONS IN MEDICINE COMPLIANT FILES ↗

  Journal of Pathology Informatics · 2022
  not yet assessed
• Abstract A003: Risks of ductal carcinoma in situ of the breast associated with pathogenic variants in cancer predisposition genes ↗

  Cancer Prevention Research · 2022
  not yet assessed
• A Population-Based Study of Genes Previously Implicated in Breast Cancer ↗

  New England Journal of Medicine · 2021 · PMID 33471974
  not yet assessed
• Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk Score ↗

  Journal of Clinical Oncology · 2021 · PMID 34101481
  not yet assessed
• Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer —Association With Patient and Disease Characteristics and Effect on Prognosis ↗

  Journal of Clinical Oncology · 2021 · PMID 33780288
  not yet assessed
• Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significance ↗

  The American Journal of Human Genetics · 2021 · PMID 33609447
  not yet assessed
• Design considerations for workflow management systems use in production genomics research and the clinic

  Scientific Reports · 2021 · PMID 34737383
  L1 57/100
• Comparison of the Prevalence of Pathogenic Variants in Cancer Susceptibility Genes in Black Women and Non-Hispanic White Women With Breast Cancer in the United States ↗

  JAMA Oncology · 2021 · PMID 34042955
  not yet assessed
• Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium ↗

  Cancer Epidemiology Biomarkers & Prevention · 2021 · PMID 33500318
  not yet assessed
• A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers ↗

  Nature Communications · 2021 · PMID 33597508
  not yet assessed
• Risk of Late-Onset Breast Cancer in Genetically Predisposed Women ↗

  Journal of Clinical Oncology · 2021 · PMID 34292776
  not yet assessed
• Mendelian randomisation study of smoking exposure in relation to breast cancer risk ↗

  British Journal of Cancer · 2021 · PMID 34341517
  not yet assessed
• Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment ↗

  Breast Cancer Research · 2021 · PMID 34407845
  not yet assessed
• Dicom_wsi: A Python Implementation for Converting Whole-Slide Images to Digital Imaging and Communications in Medicine Compliant Files ↗

  Journal of Pathology Informatics · 2021 · PMID 34267986
  not yet assessed
• CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers ↗

  British Journal of Cancer · 2021 · PMID 33495599
  not yet assessed
• A Pathologist-Annotated Dataset for Validating Artificial Intelligence: A Project Description and Pilot Study ↗

  Journal of Pathology Informatics · 2021 · PMID 34881099
  not yet assessed
• Design considerations for workflow management systems use in production genomics research and the clinic ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2021
  not yet assessed
• Using Progressive Context Encoders for Anomaly Detection in Digital Pathology Images ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2021
  not yet assessed
• Abstract PD13-01: Homologous recombination deficiency represents a new therapeutic strategy for breast cancer brain metastases ↗

  Cancer Research · 2021
  not yet assessed
• The uniform application of protein functional data has an impressive potential to resolve VUS rates in BRCA2 ↗

  Molecular Genetics and Metabolism · 2021
  not yet assessed
• Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers ↗

  Nature Communications · 2021
  not yet assessed
• Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment. ↗

  Apollo (University of Cambridge) · 2021
  not yet assessed
• Germline pathogenic variants in cancer predisposition genes among women with invasive lobular cancer of breast. ↗

  Journal of Clinical Oncology · 2021
  not yet assessed
• Additional file 3 of Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment ↗

  UWA Profiles and Research Repository (University of Western Australia) · 2021
  not yet assessed
• Additional file 1 of Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment ↗

  UWA Profiles and Research Repository (University of Western Australia) · 2021
  not yet assessed
• Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast ↗

  Journal of Clinical Oncology · 2021 · PMID 34672684
  not yet assessed
• The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort ↗

  JNCI Journal of the National Cancer Institute · 2020 · PMID 32091585
  not yet assessed
• Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer ↗

  Journal of Clinical Oncology · 2020 · PMID 32125938
  not yet assessed
• Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women ↗

  JNCI Journal of the National Cancer Institute · 2020 · PMID 32427313
  not yet assessed
• Whole‐exome sequencing of non‐ BRCA1/BRCA2 mutation carrier cases at high‐risk for hereditary breast/ovarian cancer ↗

  Human Mutation · 2020 · PMID 33326660
  not yet assessed
• Pathogenic Variants in Cancer Predisposition Genes and Prostate Cancer Risk in Men of African Ancestry ↗

  JCO Precision Oncology · 2020 · PMID 32832836
  not yet assessed
• Effect of Germline Mutations in Homologous Recombination Repair Genes on Overall Survival of Patients with Pancreatic Adenocarcinoma ↗

  Clinical Cancer Research · 2020 · PMID 33028596
  not yet assessed
• Mutation prevalence tables for hereditary cancer derived from multigene panel testing ↗

  Human Mutation · 2020 · PMID 32442341
  not yet assessed
• Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer ↗

  JNCI Journal of the National Cancer Institute · 2020 · PMID 33146377
  not yet assessed
• Prediction of the functional impact of missense variants in BRCA1 and BRCA2 with BRCA-ML ↗

  npj Breast Cancer · 2020 · PMID 32377563
  not yet assessed
• Image-to-image translation for automatic ink removal in whole slide images ↗

  Journal of medical imaging · 2020 · PMID 33102624
  not yet assessed
• Mutation Rates in Cancer Susceptibility Genes in Patients With Breast Cancer With Multiple Primary Cancers ↗

  JCO Precision Oncology · 2020 · PMID 32954205
  not yet assessed
• Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk ↗

  Scientific Reports · 2020 · PMID 32546843
  not yet assessed
• Usma Ce Model For Client Based Multidiscipline Capstones ↗

  2020
  not yet assessed
• Usma Regionalized Drinking Water Treatment Facility Multidiscipline Capstone ↗

  2020
  not yet assessed
• A Pathologist-Annotated Dataset for Validating Artificial Intelligence: A Project Description and Pilot Study ↗

  arXiv (Cornell University) · 2020
  not yet assessed
• Abstract PD3-02: Polygenic risk scores provide clinically meaningful risk stratification among women carrying moderate penetrance pathogenic variants in breast cancer predisposition genes: Results from the CARRIERS study ↗

  Cancer Research · 2020
  not yet assessed
• Metadata associated with the published article: Prediction of the functional impact of missense variants in BRCA1 and BRCA2 with BRCA-ML ↗

  Figshare · 2020
  not yet assessed
• Abstract PD3-01: Population-based breast cancer risk estimates for predisposition gene mutations: Results from the CARRIERS study ↗

  Cancer Research · 2020
  not yet assessed
• Abstract P6-08-01: Comparison of recommendations for germline genetic testing in an unselected cohort of patients with breast cancer ↗

  Cancer Research · 2020
  not yet assessed
• Abstract P6-08-04: Germline mutations in cancer predisposition genes in patients with invasive lobular carcinoma of the breast ↗

  Cancer Research · 2020
  not yet assessed
• Comparative analysis of workflow management systems in production genomics research and the clinic ↗

  2020
  not yet assessed
• F6 H=Cee ↗

  2020
  not yet assessed
• Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer ↗

  Carolina Digital Repository (University of North Carolina at Chapel Hill) · 2020
  not yet assessed
• Sentieon DNASeq Variant Calling Workflow Demonstrates Strong Computational Performance and Accuracy ↗

  Frontiers in Genetics · 2019 · PMID 31481971
  not yet assessed
• A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients ↗

  Genetics in Medicine · 2019 · PMID 31406321
  not yet assessed
• Recommendations for performance optimizations when using GATK3.8 and GATK4 ↗

  BMC Bioinformatics · 2019 · PMID 31703611
  not yet assessed
• Genome-wide association study of germline variants and breast cancer-specific mortality ↗

  British Journal of Cancer · 2019 · PMID 30787463
  not yet assessed
• Classification of Melanocytic Lesions in Selected and Whole-Slide Images via Convolutional Neural Networks ↗

  Journal of Pathology Informatics · 2019 · PMID 30972224
  not yet assessed
• Classification of variants of uncertain significance in BRCA1 and BRCA2 using personal and family history of cancer from individuals in a large hereditary cancer multigene panel testing cohort ↗

  Genetics in Medicine · 2019 · PMID 31853058
  not yet assessed
• Contribution of Inherited DNA-Repair Gene Mutations to Hormone-Sensitive and Castrate-Resistant Metastatic Prostate Cancer and Implications for Clinical Outcome ↗

  JCO Precision Oncology · 2019 · PMID 32923857
  not yet assessed
• Robust hierarchical density estimation and regression for re-stained histological whole slide image co-registration ↗

  PLoS ONE · 2019 · PMID 31339943
  not yet assessed
• American Dictators ↗

  Rutgers University Press eBooks · 2019
  not yet assessed
• Development of Youth Civic Identities Through Action Civics and Youth Participatory Action Research ↗

  Proceedings of the 2019 AERA Annual Meeting · 2019
  not yet assessed
• Robust Hierarchical Density Estimation and Regression for Re-stained Histological Whole Slide Image Co-registration ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2019
  not yet assessed
• Mutation prevalence tables for hereditary cancer derived from multi-gene panel testing ↗

  medRxiv · 2019
  not yet assessed
• Germline BRCA1and BRCA2 mutations in patients with HER2-negative metastatic breast cancer (mBC) treated with first-line chemotherapy: Data from the German PRAEGNANT registry. ↗

  Journal of Clinical Oncology · 2019
  not yet assessed
• Racial and ethnic differences in the results of multigene panel testing of inherited cancer predisposition genes in breast cancer patients. ↗

  Journal of Clinical Oncology · 2019
  not yet assessed
• Correction to: Recommendations for performance optimizations when using GATK3.8 and GATK4 ↗

  BMC Bioinformatics · 2019 · PMID 31847808
  not yet assessed
• Genetic predisposition to breast cancer among African American women. ↗

  Journal of Clinical Oncology · 2019
  not yet assessed
• Abstract 4177: The joint effects of polygenic risk scores and pathogenic variants in cancer predisposition genes on breast cancer risk in the general population: results from the CARRIERS study ↗

  Cancer Research · 2019
  not yet assessed
• Abstract 4169: Population-based breast cancer risk estimates associated with cancer predisposition gene mutations from 32,298 breast cancer patients and 31,869 matched unaffected controls from the CARRIERS study ↗

  Epidemiology · 2019
  not yet assessed
• Prediction of the functional impact of missense variants in BRCA1 and BRCA2 with BRCA-ML ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2019
  not yet assessed
• PROGRESSIVE NON-INVASIVE OBSTRUCTING ENDOBRONCHIAL ASPERGILLOMA IN AN IMMUNOCOMPETENT PATIENT SUCCESSFULLY MANAGED BRONCHOSCOPICALLY ↗

  CHEST Journal · 2019
  not yet assessed
• Abstract 4177: The joint effects of polygenic risk scores and pathogenic variants in cancer predisposition genes on breast cancer risk in the general population: results from the CARRIERS study ↗

  Epidemiology · 2019
  not yet assessed
• Abstract 4169: Population-based breast cancer risk estimates associated with cancer predisposition gene mutations from 32,298 breast cancer patients and 31,869 matched unaffected controls from the CARRIERS study ↗

  Cancer Research · 2019
  not yet assessed
• Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes ↗

  The American Journal of Human Genetics · 2018 · PMID 30554720
  not yet assessed
• Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer ↗

  JAMA · 2018 · PMID 29922827
  not yet assessed
• Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing ↗

  JNCI Journal of the National Cancer Institute · 2018 · PMID 30099541
  not yet assessed
• BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study ↗

  Journal of Clinical Oncology · 2018 · PMID 29791287
  not yet assessed
• Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models ↗

  Genetics in Medicine · 2018 · PMID 29884841
  not yet assessed
• Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes ↗

  JCO Precision Oncology · 2018 · PMID 31497750
  not yet assessed
• Cancer susceptibility gene mutations in type I and II endometrial cancer ↗

  Gynecologic Oncology · 2018 · PMID 30612635
  not yet assessed
• Will Digital Pathology be as Disruptive as Genomics? ↗

  Journal of Pathology Informatics · 2018 · PMID 30167342
  not yet assessed
• Performance benchmarking of GATK3.8 and GATK4 ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2018
  not yet assessed
• Computational performance and accuracy of Sentieon DNASeq variant calling workflow ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2018
  not yet assessed
• Germline BRCA1/2, PALB2, and ATM mutations in 3,030 patients with pancreatic adenocarcinoma: Survival analysis of carriers and noncarriers. ↗

  Journal of Clinical Oncology · 2018
  not yet assessed
• Prognostic impact of DNA repair germline variants in hormone sensitive prostate cancer stage. ↗

  Journal of Clinical Oncology · 2018
  not yet assessed
• Expanding BRCA1/2 testing criteria to include other confirmed breast and ovarian cancer susceptibility genes. ↗

  Journal of Clinical Oncology · 2018
  not yet assessed
• Association analysis identifies 65 new breast cancer risk loci ↗

  Nature · 2017 · PMID 29059683
  not yet assessed
• Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer ↗

  JAMA Oncology · 2017 · PMID 28418444
  not yet assessed
• Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer ↗

  Nature Genetics · 2017 · PMID 29058716
  not yet assessed
• Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls ↗

  Gynecologic Oncology · 2017 · PMID 28888541
  not yet assessed
• The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk ↗

  npj Breast Cancer · 2017 · PMID 28649662
  not yet assessed
• A prospective genome-wide study of prostate cancer metastases reveals association of wnt pathway activation and increased cell cycle proliferation with primary resistance to abiraterone acetate–prednisone ↗

  Annals of Oncology · 2017 · PMID 29069303
  not yet assessed
• Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands’ Susceptibility Gene Mutation Status ↗

  JNCI Journal of the National Cancer Institute · 2017 · PMID 29982661
  not yet assessed
• Empowering Mayo Clinic Individualized Medicine with Genomic Data Warehousing ↗

  Journal of Personalized Medicine · 2017 · PMID 28829408
  not yet assessed
• Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2017
  not yet assessed
• Abstract 1287: Multigene panel testing and risk estimates in 10,233 ovarian cancer cases ↗

  Cancer Research · 2017
  not yet assessed
• Abstract 4265: Risks of familial breast cancer associated with known and proposed breast cancer susceptibility genes ↗

  Cancer Research · 2017
  not yet assessed
• Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer ↗

  The American Journal of Human Genetics · 2016 · PMID 27153395
  not yet assessed
• Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer ↗

  Nature Communications · 2016 · PMID 27117709
  not yet assessed
• No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing ↗

  Journal of Medical Genetics · 2016 · PMID 26921362
  not yet assessed
• Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus ↗

  Breast Cancer Research · 2016 · PMID 27459855
  not yet assessed
• Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer ↗

  JNCI Journal of the National Cancer Institute · 2016 · PMID 28376176
  not yet assessed
• Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium ↗

  Breast Cancer Research · 2016 · PMID 27716369
  not yet assessed
• A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer ↗

  Cancer Discovery · 2016 · PMID 27655433
  not yet assessed
• Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer ↗

  BMJ Open · 2016 · PMID 27084275
  not yet assessed
• Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3 ↗

  Breast Cancer Research and Treatment · 2016 · PMID 27796716
  not yet assessed
• Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin ↗

  Journal of Translational Medicine · 2016 · PMID 27165126
  not yet assessed
• Applying the ExCEEd Teaching Model in a Flipped Classroom Environment ↗

  2016
  not yet assessed
• HARNESSING BIG DATA FOR PRECISION MEDICINE: INFRASTRUCTURES AND APPLICATIONS ↗

  2016 · PMID 27897013
  not yet assessed
• rs2735383, located at a microRNA binding site in the 3’UTR of NBS1, is not associated with breast cancer risk ↗

  Scientific Reports · 2016 · PMID 27845421
  not yet assessed
• Crowdsourcing an Outline for a Model Introductory Infrastructure Course Using a Modified Delphi Process ↗

  2016
  not yet assessed
• Implementation of Infrastructure Education Courses Across Multiple Institutions ↗

  2016
  not yet assessed
• Cancer susceptibility mutations in individuals with breast and ovarian cancer using next-generation sequencing. ↗

  Journal of Clinical Oncology · 2016
  not yet assessed
• Risks of triple negative breast cancer associated with cancer predisposition gene mutations. ↗

  Journal of Clinical Oncology · 2016
  not yet assessed
• Abstract 2597: Breast and ovarian cancer risks associated with cancer predisposition gene mutations identified by multigene panel testing ↗

  Cancer Research · 2016
  not yet assessed
• Abstract 810: The CARRIERS consortium: Establishing refined breast cancer risk estimates in known predisposition genes ↗

  Cancer Research · 2016
  not yet assessed
• Abstract 796: ERCC3 R109X is a moderate risk breast cancer risk variant in Ashkenazi Jews ↗

  Cancer Research · 2016
  not yet assessed
• Abstract 5220: Evaluation of ACMG guideline classified variants in 180 cancer and incidental non-cancer genes in families with breast/ovarian cancer ↗

  Cancer Research · 2016
  not yet assessed
• Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients ↗

  Cancer Epidemiology Biomarkers & Prevention · 2015 · PMID 26483394
  not yet assessed
• BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers ↗

  JNCI Journal of the National Cancer Institute · 2015 · PMID 26586665
  not yet assessed
• VCF-Miner: GUI-based application for mining variants and annotations stored in VCF files ↗

  Briefings in Bioinformatics · 2015 · PMID 26210358
  not yet assessed
• Mutational Landscapes of Sequential Prostate Metastases and Matched Patient Derived Xenografts during Enzalutamide Therapy ↗

  PLoS ONE · 2015 · PMID 26695660
  not yet assessed
• TP53mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer ↗

  Nucleic Acids Research · 2015 · PMID 25916844
  not yet assessed
• Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease ↗

  Cancer Research · 2015 · PMID 26676757
  not yet assessed
• Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy ↗

  Breast Cancer Research and Treatment · 2015 · PMID 26296701
  not yet assessed
• Transcriptomic and Immunohistochemical Profiling of SLC6A14 in Pancreatic Ductal Adenocarcinoma ↗

  BioMed Research International · 2015 · PMID 26106611
  not yet assessed
• Collaborative science in the next-generation sequencing era: a viewpoint on how to combine exome sequencing data across sites to identify novel disease susceptibility genes ↗

  Briefings in Bioinformatics · 2015 · PMID 26358132
  not yet assessed
• PANDA: pathway and annotation explorer for visualizing and interpreting gene-centric data ↗

  PeerJ · 2015 · PMID 26038725
  not yet assessed
• Abstract P4-12-03: Triple-negative breast cancer: Frequency of inherited mutations in breast cancer susceptibility genes ↗

  Cancer Research · 2015
  not yet assessed
• Abstract PD3-3: Impact of neoadjuvant chemotherapy on the clonal composition of breast cancer ↗

  Cancer Research · 2015
  not yet assessed
• Flipping the Infrastructure Classroom ↗

  2015
  not yet assessed
• PANDA: pathway and annotation explorer for visualizing and interpreting gene-centric data ↗

  2015
  not yet assessed
• PANDA: pathway and annotation explorer for visualizing and interpreting gene-centric data ↗

  2015
  not yet assessed
• Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer ↗

  Journal of Clinical Oncology · 2014 · PMID 25452441
  not yet assessed
• Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma ↗

  Human Pathology · 2014 · PMID 24837095
  not yet assessed
• Bioinformatics for Clinical Next Generation Sequencing ↗

  Clinical Chemistry · 2014 · PMID 25451870
  not yet assessed
• Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer ↗

  Proceedings of the National Academy of Sciences · 2014 · PMID 25288723
  not yet assessed
• The Biological Reference Repository (BioR): a rapid and flexible system for genomics annotation ↗

  Bioinformatics · 2014 · PMID 24618464
  not yet assessed
• Activation of TAK1 by MYD88 L265P drives malignant B-cell Growth in non-Hodgkin lymphoma ↗

  Blood Cancer Journal · 2014 · PMID 24531446
  not yet assessed
• Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers ↗

  Breast Cancer Research · 2014 · PMID 25919761
  not yet assessed
• PatternCNV: a versatile tool for detecting copy number changes from exome sequencing data ↗

  Bioinformatics · 2014 · PMID 24876377
  not yet assessed
• Pregnancy-associated plasma protein-A expression in human breast cancer ↗

  Growth Hormone & IGF Research · 2014 · PMID 25468445
  not yet assessed
• A Single Institution Experience in Compliance with Universal Screening for Lynch Syndrome in Colorectal Cancer ↗

  Journal of Gastrointestinal Surgery · 2014 · PMID 25504462
  not yet assessed
• From Days to Hours: Reporting Clinically Actionable Variants from Whole Genome Sequencing ↗

  PLoS ONE · 2014 · PMID 24505267
  not yet assessed
• Abstract 4185: Analysis of sequencing data to identify potential drug targets for an individual newly diagnosed with basal breast cancer who failed to respond to current standard neoadjuvant chemotherapy ↗

  Cancer Research · 2014
  not yet assessed
• Abstract 5592: Molecular classification of triple negative breast cancer via RNA-sequencing data ↗

  Cancer Research · 2014
  not yet assessed
• Abstract 3282: Determination of cancer susceptibility in probands with breast and ovarian cancer ↗

  Cancer Research · 2014
  not yet assessed
• Abstract 2378: Harmonization of next generation sequencing data within consortia for gene discovery in familial breast cancer ↗

  Cancer Research · 2014
  not yet assessed
• Abstract 1291: High and moderate penetrance germline mutations in a number of genes are responsible for a small proportion of familial breast cancer risk in BRCAx families ↗

  Cancer Research · 2014
  not yet assessed
• Abstract 1195: Feasibility of using percutaneous tumor biopsies from a prospective neoadjuvant breast cancer study to develop patient derived xenografts and assess in vivo chemotherapy sensitivity ↗

  Cancer Research · 2014
  not yet assessed
• Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk ↗

  PLoS Genetics · 2013 · PMID 23544013
  not yet assessed
• Calculating Sample Size Estimates for RNA Sequencing Data ↗

  Journal of Computational Biology · 2013 · PMID 23961961
  not yet assessed
• Genetic Alterations Associated With Progression From Pancreatic Intraepithelial Neoplasia to Invasive Pancreatic Tumor ↗

  Gastroenterology · 2013 · PMID 23912084
  not yet assessed
• APOBEC3B Upregulation and Genomic Mutation Patterns in Serous Ovarian Carcinoma ↗

  Cancer Research · 2013 · PMID 24154874
  not yet assessed
• Hepatocyte Nuclear Factor 4 Alpha and Farnesoid X Receptor Co-regulates Gene Transcription in Mouse Livers on a Genome-Wide Scale ↗

  Pharmaceutical Research · 2013 · PMID 23462932
  not yet assessed
• SoftSearch: Integration of Multiple Sequence Features to Identify Breakpoints of Structural Variations ↗

  PLoS ONE · 2013 · PMID 24358278
  not yet assessed
• Somatic expression of ENRAGE is associated with obesity status among patients with clear cell renal cell carcinoma ↗

  Carcinogenesis · 2013 · PMID 24374825
  not yet assessed
• Activation Of TAK1 By MYD88 L265P Drives Malignant B Cell Growth In Non-Hodgkin Lymphomas ↗

  Blood · 2013
  not yet assessed
• Abstract B42: Overexpression of ENRAGE is an obesity-related alteration in clear cell renal cell carcinoma ↗

  Cancer Prevention Research · 2013
  not yet assessed
• Mouse Genomic Loci Modulating Ganglion Cell Loss in Glaucoma

  Investigative Ophthalmology & Visual Science · 2013
  not yet assessed
• Biomarkers for Neuronal Injury following Blast Trauma to the Eye

  Investigative Ophthalmology & Visual Science · 2013
  not yet assessed
• Deep Sequence Analysis of Non-Small Cell Lung Cancer: Integrated Analysis of Gene Expression, Alternative Splicing, and Single Nucleotide Variations in Lung Adenocarcinomas with and without Oncogenic KRAS Mutations ↗

  Frontiers in Oncology · 2012 · PMID 22655260
  not yet assessed
• The Role of CYP3A4 mRNA Transcript with Shortened 3′-Untranslated Region in Hepatocyte Differentiation, Liver Development, and Response to Drug Induction ↗

  Molecular Pharmacology · 2011 · PMID 21998292
  not yet assessed
• A high-throughput-sequence analysis infrastructure technology investigation framework for the evaluation of next-generation sequencing software ↗

  Genome biology · 2011
  not yet assessed
• NEW APPROACHES IN UNDERSTANDING DRUG METABOLISM

  KU ScholarWorks (The University of Kansas) · 2011
  not yet assessed
• Alternative CYP3A4 mRNA Isoforms Are Related to Hepatocyte Differentiation, Liver Development, and Response to Drugs ↗

  The FASEB Journal · 2011
  not yet assessed
• Farnesoid X Receptor and Hepatocyte Nuclear Factor 4 alpha Interact to Regulate Gene Transcription in the Liver ↗

  The FASEB Journal · 2011
  not yet assessed
• A high-throughput-sequence analysis infrastructure technology investigation framework for the evaluation of next-generation sequencing software ↗

  Genome biology · 2011
  not yet assessed
• A Comparison of Whole Genome Gene Expression Profiles of HepaRG Cells and HepG2 Cells to Primary Human Hepatocytes and Human Liver Tissues ↗

  Drug Metabolism and Disposition · 2010 · PMID 20228232
  not yet assessed
• Farnesoid X Receptor Activation Mediates Head-to-Tail Chromatin Looping in theNr0b2Gene Encoding Small Heterodimer Partner ↗

  Molecular Endocrinology · 2010 · PMID 20444884
  not yet assessed
• CORRECTIONS: Genome-Wide Tissue-Specific Farnesoid X Receptor Binding in Mouse Liver and Intestine ↗

  Hepatology · 2010
  not yet assessed
• Genome‐wide tissue‐specific farnesoid X receptor binding in mouse liver and intestine† ↗

  Hepatology · 2009 · PMID 20091679
  not yet assessed
• Dynamic Patterns of Histone Methylation Are Associated with Ontogenic Expression of the Cyp3a Genes during Mouse Liver Maturation ↗

  Molecular Pharmacology · 2009 · PMID 19188337
  not yet assessed
• Dynamic DNA and histone methylation influences the ontogeny of xenobiotic metabolizing genes during postnatal mouse liver maturation ↗

  The FASEB Journal · 2009
  not yet assessed
• Dynamic patterns of histone methylation are associated with ontogenic expression of the Cyp3a genes during mouse liver maturation ↗

  The FASEB Journal · 2009
  not yet assessed
• Three Patterns of Cytochrome P450 Gene Expression during Liver Maturation in Mice ↗

  Drug Metabolism and Disposition · 2008 · PMID 18845660
  not yet assessed
• Genetic polymorphisms in cytochrome P450 oxidoreductase influence microsomal P450-catalyzed drug metabolism ↗

  Pharmacogenetics and Genomics · 2008 · PMID 18216718
  not yet assessed
• P450 oxidoreductase: genetic polymorphisms and implications for drug metabolism and toxicity ↗

  Expert Opinion on Drug Metabolism & Toxicology · 2008 · PMID 18433346
  not yet assessed
• Hylan B Gel Restores Structure and Function to Laser-Ablated Canine Vocal Folds ↗

  Annals of Otology Rhinology & Laryngology · 2008 · PMID 18834075
  not yet assessed
• Microarray analysis of the in vivo sequence preferences of a minor groove binding drug ↗

  BMC Genomics · 2008 · PMID 18215295
  not yet assessed
• Assessment of Allelic Variation Among Massasauga Rattlesnake Populations via Microsatellite Analysis ↗

  Transactions of the Missouri Academy of Science · 2008
  not yet assessed
• Single nucleotide polymorphisms in cytochrome P450 oxidoreductase influence drug metabolism ↗

  The FASEB Journal · 2008
  not yet assessed
• Genetic polymorphisms in the RNA polymerase II core promoter and enhancer elements of the UGT1A1 promoter influence activation of its gene transcription ↗

  The FASEB Journal · 2008
  not yet assessed
• Novel SNPs in Cytochrome P450 Oxidoreductase ↗

  Drug Metabolism and Pharmacokinetics · 2007 · PMID 17827787
  not yet assessed
• Effect of Hoechst 33258 on gene expression in yeast ↗

  The FASEB Journal · 2006
  not yet assessed
• Development of a Canine Model for Recurrent Respiratory Papillomatosis ↗

  Annals of Otology Rhinology & Laryngology · 2003 · PMID 14703102
  not yet assessed
• What Does the Lord Require?: How American Christians Think about Economic Justice ↗

  Review of Religious Research · 1998
  not yet assessed
• What Does the Lord Require?: How American Christians Think about Economic Justice ↗

  Review of Religious Research · 1998
  not yet assessed
• What Does the Lord Require?: How American Christians Think about Economic Justice ↗

  Review of Religious Research · 1998
  not yet assessed
• Compelling Cancer Cells to Self-Destruct ↗

  Science News · 1989
  not yet assessed